Correlation Between Unicycive Therapeutics and Aura Biosciences

Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Aura Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Aura Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Unicycive Therapeutics and Aura Biosciences, you can compare the effects of market volatilities on Unicycive Therapeutics and Aura Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Aura Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Aura Biosciences.

Diversification Opportunities for Unicycive Therapeutics and Aura Biosciences

-0.09

Correlation Coefficient

Unicycive Therapeutics  Aura Biosciences

Good diversification

The 3 months correlation between Unicycive and Aura is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Aura Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aura Biosciences and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Aura Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aura Biosciences has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Aura Biosciences go up and down completely randomly.

Pair Corralation between Unicycive Therapeutics and Aura Biosciences

Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 1.6 times more return on investment than Aura Biosciences. However, Unicycive Therapeutics is 1.6 times more volatile than Aura Biosciences. It trades about 0.23 of its potential returns per unit of risk. Aura Biosciences is currently generating about -0.04 per unit of risk. If you would invest  38.00  in Unicycive Therapeutics on September 12, 2024 and sell it today you would earn a total of  42.00  from holding Unicycive Therapeutics or generate 110.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Unicycive Therapeutics  vs.  Aura Biosciences

Unicycive Therapeutics

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Unicycive Therapeutics are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Unicycive Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Aura Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aura Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Unicycive Therapeutics and Aura Biosciences

The main advantage of trading using opposite Unicycive Therapeutics and Aura Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Aura Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aura Biosciences will offset losses from the drop in Aura Biosciences' long position.

The idea behind Unicycive Therapeutics and Aura Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.